COVID-19 treatment pill: When will it be available, and where will it be available?
WASHINGTON - The Food and Drug Administration approved an emergency use authorization on Wednesday for Pfizer's oral antiviral treatment drug against COVID-19, Paxlovid.Under the emergency use authorization, the treatment is for oral use in adults and children 12 years or older who weigh at least 40 kilograms or about 88 pounds and who are at high risk for progressing to severe COVID-19.
However, availability of Paxlovid will be limited at first and the Department of Health and Human Services will begin allocating around 65,000 courses of treatment in the first week of January to all 50 states and territories, as well as government agencies and Health Resources and Services Administration-funded health centers.According to the Department of.
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|